Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma |
| |
Authors: | Chieh Lin Alain Luciani Emmanuel Itti Taoufik El-Gnaoui Alexandre Vignaud Pauline Beaussart Shih-jui Lin Karim Belhadj Pierre Brugières Eva Evangelista Corinne Haioun Michel Meignan Alain Rahmouni |
| |
Affiliation: | 1. Imagerie Médicale, AP-HP, Groupe Henri-Mondor Albert-Chenevier, CHU Henri Mondor, 51 Avenue du Malréchal de Lattre de Tassigny, 94010, Créteil, France 2. Université Paris-Est Créteil Val de Marne, Faculté de Médecine, 94010, Créteil, France 4. INSERM Unité U955, Equipe 17, 94010, Créteil, France 3. CNRS, UMR7054, 94010, Créteil, France 5. Médecine Nucléaire, AP-HP, Groupe Henri-Mondor Albert-Chenevier, CHU Henri Mondor, 51 Avenue du Malréchal de Lattre de Tassigny, 94010, Créteil, France 6. Hématologie Clinique, AP-HP, Groupe Henri-Mondor Albert-Chenevier, CHU Henri Mondor, 51 Avenue du Malréchal de Lattre de Tassigny, 94010, Créteil, France 7. Siemens Healthcare, 9 Boulevard Finot, 93527, Saint-Denis, France 8. Department of Statistics, Stanford University, 450 Serra Mall, Stanford, CA, 94305, USA
|
| |
Abstract: | Objective To design a whole-body MR protocol using exclusively diffusion-weighted imaging (DWI) with respiratory gating and to assess its value for lesion detection and staging in patients with diffuse large B-cell lymphoma (DLBCL), with integrated FDG PET/CT as the reference standard. Methods Fifteen patients underwent both whole-body DWI (b?=?50, 400, 800 s/mm2) and PET/CT for pretreatment staging. Lymph node and organ involvement were evaluated by qualitative and quantitative image analysis, including measurement of the mean apparent diffusion coefficient (ADC). Results A total of 296 lymph node regions in the 15 patients were analysed. Based on International Working Group size criteria alone, DWI findings matched PET/CT findings in 277 regions (94%) (kappa score?=?0.85, P?0.0001), yielding sensitivity and specificity for DWI lymph node involvement detection of 90% and 94%. Combining visual ADC analysis with size measurement increased DWI specificity to 100% with 81% sensitivity. For organ involvement, the two techniques agreed in all 20 recorded organs (100%). All involved organ lesions showed restricted diffusion. Ann Arbor stages agreed in 14 (93%) of the 15 patients. Conclusion Whole-body DWI with ADC analysis can potentially be used for lesion detection and staging in patients with DLBCL. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|